Vaxcyte PCVX 深 沪
已收盘 08-29 16:00:00 美东时间
30.79
+0.020
+0.06%
华盛通- 最 高31.18
- 今 开30.75
- 成交量 94.49万股
- 最 低 30.32
- 昨 收 30.77
- 总市值 39.72亿
- 52周最高 121.055
- 市盈率 静 --
- 换手率 0.73%
- 52周最低 27.66
- 委 比 -43.56%
- 总股本 1.29亿
- 历史最高 121.055
- 量 比 0.55
- 振 幅 2.79%
- 历史最低 15.51
- 每 手 1
- 风险率 18.57%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Shares of vaccine companies are trading lower following a Daily Beast report suggesting that President Trump and Health and Human Services Robert F. Kennedy, Jr. will ban Covid-19 vaccines "within months." Also, a report suggested that a Covid-19 vaccine skeptic will lead the Covid-19 immunization task force.
Shares of vaccine companies are trading lower following a Daily Beast report su...
08-26 01:50
Vaxcyte shares are trading lower after the company reported a Q2 EPS miss.
Vaxcyte shares are trading lower after the company reported a Q2 EPS miss.
08-07 04:57
FDA's Vinayak Prasad Says No High-Quality Evidence For Benefit Of Vaccinating People Around Immunocompromised People With Covid Shots; I Don't Envision Randomized Trials Every Year For Covid Vaccines But Rather When There's Major Antigenic Shift
https://x.com/US_FDA/status/1924871996216951112
05-21 01:20
Vaxcyte shares are trading higher after the company reported better-than-expected Q1 EPS results.
Vaxcyte shares are trading higher after the company reported better-than-expect...
05-08 22:53
Vaxcyte Q1 EPS $(1.04) Beats $(1.11) Estimate
Vaxcyte (NASDAQ:PCVX) reported quarterly losses of $(1.04) per share which beat the analyst consensus estimate of $(1.11) by 6.31 percent. This is a 22.35 percent decrease over losses of $(0.85) per share from the same
05-08 04:48
Dynavax Highlights Superior Board Leadership Overseeing Long-Term Value Creation Strategy
Mails Letter to Stockholders Urging Stockholders to Vote "FOR" All Four Dynavax Director Nominees on the GOLD Proxy Card EMERYVILLE, Calif., April 29, 2025 /PRNewswire/ -- Dynavax Technologi...
04-29 19:30
Cantor Fitzgerald Initiates Coverage On Vaxcyte with Overweight Rating
Cantor Fitzgerald analyst Carter Gould initiates coverage on Vaxcyte (NASDAQ:PCVX) with a Overweight rating.
04-22 19:46
Nanox gets FDA Clearance for new imaging system, Nanox.ARC X
Nano-X Imaging (NASDAQ:NNOX) said on Thursday that it received clearance from the U.S. FDA for the Nanox.ARC X, its digital tomosynthesis device. The Nanox.ARC X system is used to produce tomographic ...
04-17 22:49
Shares of vaccine stocks are trading lower after CDC advisers begins a review of vaccine guidelines and discussed a more narrow use of COVID-19 booster shots.
Shares of vaccine stocks are trading lower after CDC advisers begins a review o...
04-16 21:45
美股大行评级 | 潜在涨幅147.43%！HC Wainwright & Co.上调Pacira BioSciences目标价至65美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1116650478822592513.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.：维持Pacira BioSciences(PCRX)"买入"评级，目标价从48美元升至65美元</p> <p>• 瑞穗：上调Amylyx Pharmaceuticals(AM
04-09 08:50
